Hosted on MSN
Trial analysis shows improvement in survival outcomes for glioblastoma patients receiving proton therapy
Previously, results from the photon cohort of the NRG-BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not demonstrate improvement in ...
Stereotactic radiosurgery (SRS) is increasingly used to treat brain metastases. The technique uses advanced, computer-guided imaging to deliver a highly targeted and intense dose of photon radiation.
A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and ...
Photon therapy offers strong outcomes in treating oropharyngeal cancers; however, some radiation can reach and damage nearby healthy tissue. The damage can lead to side effects that may be severe for ...
This new approach to photon radiation treatment marks a groundbreaking advancement in cancer care and has the potential to benefit patients across our markets. As the only healthcare provider in Asia ...
In a phase 3 trial of patients with stage III or IV oropharyngeal cancer, intensity-modulated proton therapy (IMPT) resulted in noninferior progression-free survival and better overall survival than ...
Nadya El-Afandi was nearing the end of breast cancer treatment when she received earth-shattering news: Doctors had diagnosed her with glioblastoma, a rapidly growing and aggressive brain tumor.
Previously, results from the photon cohort of the NRG-BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not demonstrate improvement in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results